Related Experiment Video
Updated: Aug 17, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer
Caipeng Qin1, Jing Wang2, Yiqing Du1
1Department of Urology, Peking University People's Hospital, Beijing, China.
Rationale:
To invest the role of androgen deprivation therapy (ADT) on the tumor immune microenvironment of prostate cancer.
Methods:
Here we have profiled the transcriptomes of 19,227 single cells from 4 prostate tumors, including two cases who received ADT. To validated the single-cell analysis we use another group of patients receiving neoadjuvant ADT.
Results:
After receiving ADT treatment, the killing effect of prostate cancer immune cells on tumors is weakened, the interaction between immune cells and tumor cells is weakened, and the proportion of immunosuppressive cells Myeloid-derived suppressor cell (MDSC) and Regulatory T cells (Treg) cells increases.
Conclusions:
Our results highlight that ADT induces immunosuppressive in the prostate tumor microenvironment. These data have important implications for combining ADT with immunotherapy.
Insights
Androgen deprivation therapy (ADT) weakens prostate cancer immune cell activity and increases immunosuppressive cells. This suggests ADT may hinder effective immunotherapy responses in prostate cancer patients.
Area of Science:
- Oncology
- Immunology
- Genitourinary Cancer Research
Background:
- Prostate cancer treatment often involves androgen deprivation therapy (ADT).
- The impact of ADT on the tumor immune microenvironment (TIME) is not fully understood.
- Understanding TIME changes is crucial for optimizing cancer therapies.
Purpose of the Study:
- To investigate the effects of ADT on the immune cell landscape within prostate tumors.
- To determine how ADT influences the interactions between immune cells and prostate cancer cells.
- To identify potential therapeutic strategies combining ADT with immunotherapy.
Main Methods:
- Single-cell RNA sequencing was performed on 19,227 cells from 4 prostate tumors.
- Tumor samples included cases with and without prior ADT.
- Validation was conducted using an additional cohort of patients receiving neoadjuvant ADT.
Main Results:
- ADT treatment led to a diminished cytotoxic effect of immune cells on prostate tumors.
- Interactions between immune cells and tumor cells were reduced post-ADT.
- An increased proportion of immunosuppressive cells, including Myeloid-Derived Suppressor Cells (MDSCs) and Regulatory T cells (Tregs), was observed.
Conclusions:
- ADT induces an immunosuppressive tumor microenvironment in prostate cancer.
- These findings have significant implications for the combination of ADT with cancer immunotherapy.
- Further research is warranted to explore strategies to overcome ADT-induced immunosuppression.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cell-mediated Immune Responses

